Symbol
| SRC
| contributors: mct/npt/pgu - updated : 19-06-2019
|
HGNC name
| v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
|
HGNC id
| 11283
|
corresponding disease(s)
|
THC6
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
in a small proportion of endometrial carcinoma and colon cancer | tumoral
|  
| deletion
|  
|  
|
in some leukemia | tumoral
|  
|  
| --over
|  
|
in some cancers | constitutional
|  
|  
| --over
|  
|
results in the tyrosine phosphorylation and cytoplasmic localization of RUNX3 | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | stomach | |
RUNX3 can be relocalized in the nucleus by an SRC inhibitor, in gastric cancers, providing an additional rationale for developing SRC inhibitors as anti-cancer drugs | cancer | reproductive | breast | |
RUNX3 can be relocalized in the nucleus by an SRC inhibitor, in breast cancers, providing an additional rationale for developing SRC inhibitors as anti-cancer drugs | immunology | inflammatory | | |
both SRC and NOS3 inhibition may be important therapeutic targets to prevent or limit vascular inflammation |
| | | |
| despite normal phosphorylation, sperm from cSrc null mice display a severe reduction in forward motility, and are unable to fertilize |